Skip to main content
Tech.euFundingExplorerBeta

GlycoEra

GlycoEra is a CustomGlycanengineering platform that unlocks the glycan-mediated biology to develop a pipeline of novel therapeutics.

GlycoEra has raised €157M across 2 funding rounds from 12 investors, most recently a Series B round in May 2025. Based in Schlieren, Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€157M
€157,058,306
Funding rounds
2
Investors
12
distinct backers
Active since
2021-11
latest 2025-05

Funding by year

EUR raised per year
GlycoEra — funding by year — interactive chart.
Data table
GlycoEra — funding by year
2021€43M
2025€114M

Signals

High confidence
Raise-next likelihood77
base rate 48% for Series B
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood21
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 5y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Similar companies

same sector or country

Global coverage: FundingData